SOPH Chief Medical Officer Philippe Menu Sells 5,000 Shares

What Happened

• Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold 5,000 shares in an open-market transaction on August 25, 2026.
• The filing reports a weighted-average sale price of $8.68 per share, for total proceeds of $43,397. The shares were sold in multiple trades at prices ranging from $8.37 to $8.84.

Key Details

• Transaction date: 2026-08-25; Filing date: 2026-08-26 (timely filing).
• Transaction type: Sale (Code S).
• Shares sold: 5,000; weighted-average price: $8.68; proceeds: $43,397.
• Price range (per footnote): $8.37 to $8.84; reporter will provide a breakdown of quantities at each price upon written request.
• Footnote: Transaction made pursuant to a pre-existing Rule 10b5-1 trading plan.
• Shares owned after transaction: Not specified in the Form 4 excerpt.

Context

• Sales under a 10b5-1 plan are pre-arranged and typically follow a set schedule or algorithm; they do not necessarily reflect the insider’s current view of the company.
• For retail investors, purchases generally carry more signal than routine sales. This single modest sale (≈$43k) is not unusual for an executive and should be considered alongside other insider activity and company fundamentals.